Clinical Trial

Streamlining Radioembolization for Small HCC

Study acronym: ISTAR-02
Recruiting
View on ClinicalTrials.gov →
Summary
In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel, tumor size \< 5cm), radioembolization is performed without MAA scan with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and streamlining radioembolization is feasible and safe.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-05-11; most recent amendment 2026-04-05.
Status change: Not Yet Recruiting → Recruiting 2025-06-20
Trial Details
NCT Number NCT06979219
Lead Sponsor Seoul National University Hospital
Conditions Hepatocellular Carcinoma (HCC)
Enrollment 146 participants
Start Date 2025-06-10
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-09